Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dom.12878 http://scihub22266oqcxt.onion/10.1111/dom.12878 C5484336!5484336!28094466     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Obes+Metab 2017 ; 19 (6): 800-8 Nephropedia Template TP {{tp|p=28094466|t=2017. Effects of ??blockers on all?cause mortality in patients with type 2 diabetes and coronary heart disease |pdf=|usr=}}{{28094466}} gab.com Text Effects of blockers on all cause mortality in patients with type 2 diabetes and coronary heart disease JO: Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=28094466 #FOAvip Aims: To assess whether the use of beta?blockers influences mortality and the incidence of major cardiovascular events in patients with diabetes and coronary heart disease (CHD). Materials and methods: Using data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial, we performed Cox proportional hazards analysis to assess the effects of ??blockers on all?cause mortality in 2244 patients with type 2 diabetes who had stable CHD with and without a history of myocardial infarction (MI)/heart failure with reduced left ventricular ejection fraction (HFrEF). Results: All?cause mortality in patients with MI/HFrEF was significantly lower in those receiving ??blockers than in those not receiving ??blockers (adjusted hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.37?0.98; P?=?.04), whereas that in patients without MI/HFrEF did not significantly differ (adjusted HR 0.91, 95% CI 0.76?1.32; P?=?.64). Among patients with MI/HFrEF, all?cause mortality in those who received intensive medical therapy alone for CHD was significantly lower in those on ??blockers than in those not on ??blockers (adjusted HR 0.45, 95% CI 0.23?0.88; P?=?.02); however, mortality in patients who received early revascularization for CHD was not significantly lower in those on ??blockers (adjusted HR 0.81, 95% CI 0.40?1.65; P?=?.57). The risk of major cardiovascular events in patients without MI/HFrEF was not significantly different between those on and those not on ??blocker treatment. Conclusions: In patients with diabetes and CHD, the use of ??blockers was effective in reducing all?cause mortality in those with MI/HFrEF but not in those without MI/HFrEF. Twit Text FOAVip Effects of blockers on all cause mortality in patients with type 2 diabetes and coronary heart disease ????Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=28094466 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28094466 #FOAvip English Wikipedia <ref>{{Cite pmid|28094466}}</ref> Effects of ??blockers on all?cause mortality in patients with type 2 diabetes and coronary heart disease #MMPMID28094466 Tsujimoto T; Sugiyama T; Kajio H Diabetes Obes Metab 2017[Jun]; 19 (6): 800-8 PMID28094466show ga Aims: To assess whether the use of beta?blockers influences mortality and the incidence of major cardiovascular events in patients with diabetes and coronary heart disease (CHD). Materials and methods: Using data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial, we performed Cox proportional hazards analysis to assess the effects of ??blockers on all?cause mortality in 2244 patients with type 2 diabetes who had stable CHD with and without a history of myocardial infarction (MI)/heart failure with reduced left ventricular ejection fraction (HFrEF). Results: All?cause mortality in patients with MI/HFrEF was significantly lower in those receiving ??blockers than in those not receiving ??blockers (adjusted hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.37?0.98; P?=?.04), whereas that in patients without MI/HFrEF did not significantly differ (adjusted HR 0.91, 95% CI 0.76?1.32; P?=?.64). Among patients with MI/HFrEF, all?cause mortality in those who received intensive medical therapy alone for CHD was significantly lower in those on ??blockers than in those not on ??blockers (adjusted HR 0.45, 95% CI 0.23?0.88; P?=?.02); however, mortality in patients who received early revascularization for CHD was not significantly lower in those on ??blockers (adjusted HR 0.81, 95% CI 0.40?1.65; P?=?.57). The risk of major cardiovascular events in patients without MI/HFrEF was not significantly different between those on and those not on ??blocker treatment. Conclusions: In patients with diabetes and CHD, the use of ??blockers was effective in reducing all?cause mortality in those with MI/HFrEF but not in those without MI/HFrEF. äEffects of ??blockers on all?cause mortality in patients with type 2 d(epmc).pdf DeepDyve Pubget Overpricing